Old Web
English
Sign In
Acemap
>
authorDetail
>
Kaleb J. Todd
Kaleb J. Todd
Anschutz Medical Campus
Cancer research
Melanoma
MCL1
In vivo
Biology
2
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
2020
Cell Death and Disease
Nabanita Mukherjee
Jenette Skees
Kaleb J. Todd
Drake A. West
K. Lambert
William A. Robinson
Carol M. Amato
Kasey L. Couts
Robert Van Gullick
Morgan MacBeth
Kelsey W. Nassar
Aik Choon Tan
Zili Zhai
Mayumi Fujita
Stacey M. Bagby
Chiara R. Dart
James R. Lambert
David A. Norris
Yiqun G. Shellman
Show All
Source
Cite
Save
Citations (22)
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
2020
Cancers
Nabanita Mukherjee
Carol M. Amato
Jenette Skees
Kaleb J. Todd
Karoline A. Lambert
William A. Robinson
Robert Van Gulick
Ryan M. Weight
Chiara R. Dart
Richard P. Tobin
Martin D. McCarter
Mayumi Fujita
David A. Norris
Yiqun G. Shellman
Show All
Source
Cite
Save
Citations (6)
1
map